Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study
Baber, U;
Sartori, S;
Aquino, M;
Kini, A;
Kapadia, S;
Weiss, S;
Strauss, C;
Muhlestein, JB;
Toma, C;
Rao, SV;
+12 more...Defranco, A;
Poddar, KL;
Chandrasekhar, J;
Weintraub, W;
Henry, TD;
Bansilal, S;
Baker, BA;
Marrett, E;
Keller, S;
Effron, M;
Pocock, S;
Mehran, R;
(2017)
Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study.
American heart journal, 188.
pp. 73-81.
ISSN 0002-8703
DOI: https://doi.org/10.1016/j.ahj.2017.02.013
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
Background and objectivesWe sought to determine the frequency of use and association between prasugrel and outcomes in acute coronary syndrome patients undergoing percutaneous coronary intervention (PCI) in clinical practice.